Investment and expertise
for promising, early-stage
Scottish technology and
life science companies.
WHAT WE DO
We are a prominent
business angel syndicate,
which has been at the
forefront of early stage
investing in Scotland for
more than two decades.
SEE OUR MEMBER BENEFITS
We invest in companies
from the technology,
software and life sciences
sectors – three markets in
which Scotland produces
a wealth of talent.
SEE IF YOU MEET THE CRITERIA

Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

Sorting:
  • Revolutionary Hearing Test Set To Turn Heads With Archangels’ Investment

    An innovative new system that has the potential to revolutionise hearing tests globally has received financial backing from Archangels Edinburgh-based Hearing Diagnostics Limited has received £715,000 of investment which will enable its hearing test system to undergo trials with universities and hearing aid retailers in the UK with a view to full market launch in […]

  • PhysioMedics Steps in to Tackle Covid19 Lockdown Neck and Back Pain Emergency

    Millions of workers operating from home could be creating a backlog of neck and back pain complaints which the NHS will struggle to cope with. Now physiotherapy experts at PhysioWizard®, the UK’s first clinically validated digital triage service for muscle and joint problems, are so concerned that they have stepped in to offer their online […]

  • Arrayjet Signs Seven Figure US Contract

    Arrayjet has signed a seven-figure deal with CDI Laboratories to further the US firm’s research and development programme. The contract is said to be worth in the region of $1 million (£797,000) and is the second installation of Arrayjet equipment at CDI. The new IRIS Optical system joins the Arrayjet Ultra Marathon II microarray printer […]

  • Archangels Leads Further Investment in Scottish Innovators During Lockdown

    Archangels has led investment of £3.3 million in innovative Scottish companies during the Coronavirus lockdown. Archangels’ Q2 (1st April – 30th June) deals data released today (7th July, 2020) reveals that three of our portfolio companies – Calcivis, BDD and Reactec – have received follow-on funding during the period, with £1.9m of the committed investment […]

  • Reactec Funding Round Supports Development of Social Distancing Tech

    Edinburgh-based Reactec has completed a further £700,000 round of fundraising for the ongoing development of its innovative personal monitoring equipment and reporting technology. This will include its recently launched innovative SAFE-DISTANCE device to enable social distancing among workers. The funding round was led by Archangels, with co-funding from Scottish Investment Bank, the investment arm of […]

  • MGB Biopharma Announces Successful Outcome from Phase II Clinical Study

    Study confirms MGB-BP-3 offers the potential for a new gold standard in treating Clostridium difficile Infection MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, today announces the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI). The study confirms that the drug […]

Company portfolio

  • Archangel Investors Ltd
  • Archangel Investors Ltd
  • Archangel Investors Ltd
  • RT @Blackford: Planning to attend AIMed Radiology virtual conference on November 5? Then tune in at 3:10 PM! Blackford CEO Ben Panter will…
    Archangel Investors Ltd about 1 days ago
  • RT @speechgraphics: Speech Graphics are looking for a Speech Data Engineer to join our Data Team! This is your chance to join an exciting…
    Archangel Investors Ltd about 3 days ago
  • RT @AngelNews: @hear_diags, a revolutionary hearing test, has secured a £715,000 investment from @ArchangelInvest to enable its hearing tes…
    Archangel Investors Ltd about 10 days ago

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.